Back

The incidence and clinical impact of peri-stent contrast staining after first, second, and third-generation drug-eluding stent implantation

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 6 - Coronary artery disease: diagnosis, pharmacotherapy and revascularisation Revascularisation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Kasumi Ishibuchi

Higashi Takarazuka Satoh Hospital, Takarazuka (Japan)

19 More presentations in this session

Presentation thumbnail
Practice-level variation in use of optimal medical treatment during hospitalization: a multi-level methodological approach
Professor J. Lee (Daegu, KR)
Abstract
Presentation thumbnail
Moderate versus high-intensity statin therapy in east asian patients with angina undergoing PCI with DES: a propensity-score matching analysis
Doctor M. Park (Daejeon, KR)
Abstract Slides
Presentation thumbnail
Effectiveness and tolerability of trimetazidine 80 mg od for the treatment of stable angina pectoris in 3066 patients in routine clinical practice: results from ODA trial
Professor M. Glezer (Moscow, RU)
Abstract
Presentation thumbnail
Impact of serum fibrinogen on 2-year mortality following percutaneous coronary intervention--a large cohort study from china
Doctor P. Jiang (Beijing, CN)
Abstract
Presentation thumbnail
Predictors of No-reflow in Primary PCI patients with novel insight on thrombus aspiration.
Professor A. Hassan (Assiut, EG)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 6 - Coronary artery disease: diagnosis, pharmacotherapy and revascularisation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources